References within the Medicinal Hashish phase, the businesses come collectively to supply merchandise that elevate the effectiveness of palliative care to new ranges.
SAO PAULO, BRAZIL, July 30, 2021 /EINPresswire.com/ — Quantum Farma, a UK based mostly firm that gives excessive grade cannabinoid containing services to sufferers in Latin America and different areas, in a strategic partnership with FarmaUSA, an organization specializing within the manufacture and import of medicines and a pioneer in Medicinal Cannabinoids in Brazil, promise a milestone within the Brazil’s pharmacy market.
Collectively, on July 28, they launched two progressive medicine at an unique on-line occasion for greater than 600 docs: Medrosan Forte, which has a excessive focus of THC, and Medrosan Further, which incorporates cannabigerol, a brand new kind of cannabinoid whose prescription is rising worldwide.
Organically produced, MEDROSAN Forte and MEDROSAN Further are originated from pure genetic seeds, developed by Swiss firm Medropharm and audited by the Swiss Medicines Company, from the seed to the bottle.
MEDROSAN Forte combines Cannabidiol (CBD) (75mg/ml) and Tetrahydrocannabinol (THC) (9mg/ml), cannabinoids with very excessive therapeutic potential (CBD:THC 8:1). It is likely one of the highest dosages of THC in a Full Spectrum hashish product in Brazil, fully produced within the pharmaceutical space in Switzerland. Research world wide have demonstrated the potential of such a product as an adjuvant within the remedy of signs associated to chemotherapy, contributing to the reduction of ache, nausea and lack of urge for food, in addition to in signs in fibromyalgia and palliative care.
MEDROSAN Further, alternatively, presents Cannabigerol (CBG) (50mg/ml) + Cannabidiol (CBD) (12.5mg/ml) (CBG:CBD 4:1). It’s a medicinal hashish product that, though THC-free, is Full Spectrum because it comes from a plant with pure genetics, which produces undetectable quantities of THC and accommodates CANNABIGEROL, the cannabinoid that’s quick gaining market share and recognition inside the scientific neighborhood. Its formulation combines CBG and CBD, in synergy, along with being THC-free. Among the many doable purposes are: anti-inflammatory (on this respect, rather more highly effective than cannabidiol) and highly effective muscle relaxant, along with being preferrred for individuals who can’t use THC.
“Quantum Farma is dedicated to bringing prime quality Swiss GMP medicines to Latin America. We’re excited to contribute to the entry of Medrosan Forte and Further in all areas of Brazil”, says Karan S. Madan, CEO of Quantum Farma.
“These releases reinforce FarmaUSA’s mission, which is to supply unique, progressive and world-renowned therapies for the nationwide territory, contributing to a greater high quality of life for sufferers and providing all of the assist of data and data in order that docs really feel protected of their prescriptions”, says Helder Dário Colmenero, Technical Director of FarmaUSA.
About Quantum Farma
Quantum Farma is a worldwide healthcare firm that acts as a distribution agent for pharmaceutical merchandise containing cannabinoids and supplies providers to sufferers in Latin America and different areas. The corporate serves a broad cross-section of sufferers and customers by delivering premium high quality services the place they’re wanted most.
FarmaUSA is a pharmaceutical firm based in 2005 within the USA and has been working in Brazil since 2013, turning into the primary in Medicinal Hashish, with the aim of offering humanized entry to unique therapies for 1000’s of sufferers, with progressive and famend medicines, akin to Purodiol, Isodiolex and Nabix. FarmaUSA promotes, with an moral method, related data to 1000’s of physicians all through Brazil and has a robust dedication to all households.
Medropharm GmbH specializes within the extraction, manufacturing and advertising of pharmaceutical-grade and cannabinoid-containing merchandise that actively contribute to the preservation of well being and high quality of life. All underneath Swiss Medicines Company certification.